14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 OTLK stock ended at $8.50. This is 1.16% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.44% from a day low at $8.45 to a day high of $8.91.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Outlook Therapeutics Inc. prices

Date Open High Low Close Volume
Feb 02, 2017 $3.50 $3.50 $3.39 $3.49 15 868
Feb 01, 2017 $3.61 $3.63 $3.36 $3.50 38 193
Jan 31, 2017 $3.60 $3.65 $3.41 $3.56 69 555
Jan 30, 2017 $3.78 $3.80 $3.51 $3.57 118 414
Jan 27, 2017 $3.00 $3.95 $2.98 $3.74 384 814
Jan 26, 2017 $2.83 $3.30 $2.82 $3.06 208 896
Jan 25, 2017 $2.85 $2.94 $2.78 $2.80 6 715
Jan 24, 2017 $2.85 $2.85 $2.76 $2.82 8 506
Jan 23, 2017 $2.83 $2.83 $2.76 $2.79 8 620
Jan 20, 2017 $2.94 $2.94 $2.76 $2.81 20 961
Jan 19, 2017 $2.85 $2.97 $2.76 $2.76 11 806
Jan 18, 2017 $2.99 $3.01 $2.71 $2.80 49 254
Jan 17, 2017 $3.06 $3.15 $2.83 $3.14 13 317
Jan 13, 2017 $2.92 $3.50 $2.75 $2.94 152 103
Jan 12, 2017 $3.05 $3.13 $2.70 $2.82 35 322
Jan 11, 2017 $3.19 $3.19 $2.86 $2.88 36 402
Jan 10, 2017 $2.89 $2.98 $2.77 $2.85 10 123
Jan 09, 2017 $3.00 $3.00 $2.81 $2.85 12 640
Jan 06, 2017 $2.91 $2.95 $2.86 $2.90 37 396
Jan 05, 2017 $3.09 $3.14 $2.92 $2.94 8 094
Jan 04, 2017 $3.68 $3.68 $2.80 $3.02 34 113
Jan 03, 2017 $3.05 $3.72 $3.05 $3.28 30 034
Click to get the best stock tips daily for free!

About Outlook Therapeutics Inc.

Outlook Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice... OTLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT